Literature DB >> 15574384

Immune peptide enhancement of peptide based vaccines.

Ken S Rosenthal1.   

Abstract

Vaccines optimize the presentation of an immunogen to the immune system, oftentimes enhancing or replacing the natural activators of antigen presenting cells in order to promote the delivery and the response of T and B lymphocytes to the immunogen. The purpose of this series is to describe new technologies which allow vaccine design, based on our understanding of the immune response, using different approaches to immune peptide enhancement of peptide based vaccines. In this introduction to the series entitled, "Immune Peptide Enhancement of Peptide Based Vaccines", some of the immunological concepts relevant to vaccine design are presented.

Mesh:

Substances:

Year:  2005        PMID: 15574384     DOI: 10.2741/1543

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  3 in total

Review 1.  Vaccines: all things considered.

Authors:  Ken S Rosenthal; Daniel H Zimmerman
Journal:  Clin Vaccine Immunol       Date:  2006-08

2.  LEAPS therapeutic vaccines as antigen specific suppressors of inflammation in infectious and autoimmune diseases.

Authors:  Daniel H Zimmerman; Harold Steiner; Roy Carmabula; Eyal Talor; Ken S Rosenthal
Journal:  J Vaccines Vaccin       Date:  2012-09-20

Review 3.  J-LEAPS peptide and LEAPS dendritic cell vaccines.

Authors:  Ken S Rosenthal; Patricia Taylor; Daniel H Zimmerman
Journal:  Microb Biotechnol       Date:  2011-09-06       Impact factor: 5.813

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.